Latham Partner Receives Prestigious Life Science Award

BayBio

December 12, 2014

Alan Mendelson, a partner in the Silicon Valley office of Latham & Watkins LLP and a global Co-chair of the firm’s Life Sciences Industry Group, was honored with BayBio’s 2014 Life Science Leadership Award. The BayBio Pantheon Awards, popularly known as the life sciences “Oscars” in Northern California, recognized Mendelson for his “pioneering leadership in helping numerous emerging biotech companies get their start and unwavering encouragement of their efforts to bring drugs and medical devices to market, and for promoting the Northern California life science cluster.” 

Mendelson is also the first honoree since the Pantheon Awards’ inception 13 years ago to have been chosen from within the professional services community, emphasizing his extraordinary leadership and achievements as a trusted advisor to the life sciences industry. Over the course of his career, Mendelson has counseled numerous life sciences clients on a variety of major business transactions in the sector, including venture capital financings, private placements and public offerings, mergers and acquisitions, joint ventures, and other strategic collaborations and commercial transactions. 

Watch Mendelson’s tribute video and award presentation at the BayBio Pantheon Awards.

Previous honorees of the prestigious Pantheon Award include: Herbert W. Boyer and Robert Swanson, co-founders of Genentech; George B. Rathmann, co-founder of Amgen, Inc. and founder of ICOS Corporation; Kary Banks Mullis, Nobel Prize winner in chemistry for his invention of the polymerase chain reaction (PCR) thus making it possible to map the structure and function of DNA; Brook Byers, who formed the first Life Sciences practice group in the venture capital profession and led Kleiner Perkins Caufield & Byers (KPCB) to become a premier venture capital firm in the medical, healthcare and biotechnology sectors; and many others who have made similarly pioneering and substantial contributions to the industry.

 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.